Research record changes

The latest 100 trial status and retraction changes detected since change tracking began. Dates show when RareWays recorded the change, which may be later than the source update. Earlier history is unavailable.

1. Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis

   ACTIVE NOT RECRUITING → UNKNOWN

   Recorded 2026-10-20

   View record

2. BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome

   RECRUITING → ACTIVE NOT RECRUITING

   Recorded 2026-10-20

   View record

3. Forecasting Relapse Outcomes With AlloHeme-based Risk Detection in Post-Allo-HCT AML/MDS Patients (FORWARD)

   NOT YET RECRUITING → ENROLLING BY INVITATION

   Recorded 2026-10-16

   View record

4. Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test

   ACTIVE NOT RECRUITING → COMPLETED

   Recorded 2026-10-16

   View record

5. Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

   RECRUITING → SUSPENDED

   Recorded 2026-10-15

   View record

6. Phase I Study of FXS0683 in the Treatment of Blood Tumors

   NOT YET RECRUITING → RECRUITING

   Recorded 2026-10-14

   View record

7. CD34+ Enriched Transplants to Treat Myelodysplastic Syndrome

   SUSPENDED → NOT YET RECRUITING

   Recorded 2026-10-14

   View record

8. Ascorbate in Myelodysplastic Syndrome

   RECRUITING → SUSPENDED

   Recorded 2026-10-09

   View record

9. Revisiting the Universal Donor: Does Exposure to O Blood Products Affect Patient Outcomes?

   RECRUITING → COMPLETED

   Recorded 2026-10-08

   View record

10. Asia Myelodysplastic Syndrome (MDS) Registry

    NOT YET RECRUITING → RECRUITING

    Recorded 2026-10-08

    View record

11. Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies

    ACTIVE NOT RECRUITING → COMPLETED

    Recorded 2026-10-06

    View record

12. Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy

    ACTIVE NOT RECRUITING → COMPLETED

    Recorded 2026-10-02

    View record

13. The Tapering Dose of Luspatercept in Patients With Lower-risk Myelodysplastic Syndromes

    RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record

14. Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations

    RECRUITING → SUSPENDED

    Recorded 2026-10-01

    View record

15. Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies

    ACTIVE NOT RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record

16. Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid Leukemia

    ACTIVE NOT RECRUITING → TERMINATED

    Recorded 2026-10-01

    View record

17. Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

    ACTIVE NOT RECRUITING → TERMINATED

    Recorded 2026-10-01

    View record

18. Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory

    RECRUITING → SUSPENDED

    Recorded 2026-10-01

    View record

19. A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics

    RECRUITING → TERMINATED

    Recorded 2026-10-01

    View record

20. A Trial to Evaluate the Safety and Efficacy of NK Cells in Subjects With Myelodysplastic Syndromes

    NOT YET RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record

21. Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes

    ACTIVE NOT RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record

22. ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

    RECRUITING → SUSPENDED

    Recorded 2026-10-01

    View record

23. Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms

    RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record

24. Hypomemylating Agents Combination With eDC Therapy for Elderly Patients With Myelodysplastic Syndrome

    RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record

25. Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML

    ACTIVE NOT RECRUITING → TERMINATED

    Recorded 2026-10-01

    View record

26. CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

    ACTIVE NOT RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record

27. DR-18 to Prevent or Treat Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse After Hematopoietic Cell Transplantation, the DR. DREAM Trial

    RECRUITING → SUSPENDED

    Recorded 2026-10-01

    View record

28. ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic Syndrome

    RECRUITING → TERMINATED

    Recorded 2026-10-01

    View record

29. Evaluation of 3 Different Doses of IV Busulfan

    ACTIVE NOT RECRUITING → COMPLETED

    Recorded 2026-10-01

    View record

30. Immunophenotyping of Blood Cells in the Diagnosis Work-up of Myelodysplastic Syndromes

    RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record

31. Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

    RECRUITING → TERMINATED

    Recorded 2026-10-01

    View record

32. A Study to Evaluate Treatment Patterns and Effectiveness of Luspatercept

    ACTIVE NOT RECRUITING → COMPLETED

    Recorded 2026-10-01

    View record

33. A Single-arm Trial of Roxadustat Combined With Retinoic Acid in the Treatment of Refractory Low-risk MDS

    NOT YET RECRUITING → WITHDRAWN

    Recorded 2026-10-01

    View record

34. A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm

    RECRUITING → WITHDRAWN

    Recorded 2026-10-01

    View record

35. Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia

    ACTIVE NOT RECRUITING → TERMINATED

    Recorded 2026-10-01

    View record

36. Pacritinib With Aza for Upfront Myelodysplastic Syndrome

    NOT YET RECRUITING → WITHDRAWN

    Recorded 2026-10-01

    View record

37. Transfusion in Lower Risk MDS Patients: Predictors of Adequacy of Transfusion and Quality of Life in Lower Risk MDS

    RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record

38. Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

    RECRUITING → TERMINATED

    Recorded 2026-10-01

    View record